The pivotal discovery that donor heterologous myoblasts could restore dystrophin expression in the dystrophin deficient mdx mouse 29 set the precedent for a number of human clinical trials in DMD patients in the 1990s 30. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.